EPS for Exponent, Inc. (EXPO) Expected At $0.60

June 14, 2018 - By Maria Brooks

Exponent, Inc. (NASDAQ:EXPO) LogoInvestors sentiment decreased to 1.31 in 2018 Q1. Its down 0.35, from 1.66 in 2017Q4. It turned negative, as 14 investors sold Exponent, Inc. shares while 56 reduced holdings. 24 funds opened positions while 68 raised stakes. 22.31 million shares or 0.02% less from 22.32 million shares in 2017Q4 were reported.
Roffman Miller Assoc Pa owns 160,459 shares. Cambridge Research Advisors accumulated 5,551 shares. Bancorporation Of Mellon Corporation accumulated 376,629 shares. Vanguard owns 0.01% invested in Exponent, Inc. (NASDAQ:EXPO) for 2.43 million shares. California Employees Retirement Systems reported 81,164 shares or 0.01% of all its holdings. Moreover, Deutsche Bankshares Ag has 0% invested in Exponent, Inc. (NASDAQ:EXPO). Arrowstreet Cap Limited Partnership holds 0% or 18,606 shares in its portfolio. Royal Comml Bank Of Canada invested in 0% or 32,375 shares. Stone Ridge Asset Management Ltd Liability holds 6,308 shares or 0.03% of its portfolio. Aviance Cap Lc stated it has 4,000 shares or 0.09% of all its holdings. Rhumbline Advisers reported 71,392 shares. 209,068 are owned by Copeland Limited Liability. Comerica National Bank & Trust stated it has 0.03% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). The Australia-based Macquarie Grp Incorporated Limited has invested 0% in Exponent, Inc. (NASDAQ:EXPO). Jacobs Levy Equity Management invested in 0.01% or 10,241 shares.

Since May 7, 2018, it had 0 insider purchases, and 6 selling transactions for $3.78 million activity. $2.57M worth of Exponent, Inc. (NASDAQ:EXPO) was sold by SCHLENKER RICHARD L JR. 500 Exponent, Inc. (NASDAQ:EXPO) shares with value of $48,004 were sold by Zumwalt Debra. Pye John sold 3,600 shares worth $322,154. Another trade for 2,639 shares valued at $248,161 was sold by Kytomaa Harri.

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $0.60 EPS on July, 17.They anticipate $0.09 EPS change or 17.65 % from last quarter’s $0.51 EPS. EXPO’s profit would be $15.60M giving it 20.77 P/E if the $0.60 EPS is correct. After having $0.61 EPS previously, Exponent, Inc.’s analysts see -1.64 % EPS growth. The stock increased 1.22% or $0.6 during the last trading session, reaching $49.85. About 226,231 shares traded. Exponent, Inc. (NASDAQ:EXPO) has risen 61.24% since June 14, 2017 and is uptrending. It has outperformed by 48.67% the S&P500.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting firm worldwide. The company has market cap of $1.30 billion. The Company’s services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. It has a 32.58 P/E ratio. The firm operates in two divisions, Engineering and Other Scientific, and Environmental and Health.

Exponent, Inc. (NASDAQ:EXPO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: